Less Common But Important Semaglutide Side Effects Beyond gastrointestinal symptoms, some patients report headaches, dizziness, fatigue, or muscle aches during the first few weekstypically mild and self-limiting
Key findings from clinical trials include: Reductions in waist circumference, an indirect marker of abdominal fat Improvements in metabolic markers associated with visceral adiposity (HbA1c, lipid profiles, liver enzymes) Decreased hepatic fat content in patients with fatty liver disease It is important to understand that GLP-1 medications do not 'burn' fat through thermogenesis or direct lipolysis
Ongoing research continues to explore its potential applications in nonalcoholic fatty liver disease (NAFLD), where a 2019 trial published in Lancet HIV demonstrated a 32% relative reduction in hepatic fat fraction over 12 months
The majority of the total body sodium ion is found in the extracellular fluids
This action is especially important for people with Type 2 diabetes, whose pancreas does not produce enough insulin